Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a κ-opioid receptor agonist in mononeuropathic rats

European Journal of Pharmacology

Volumn 357, Issue 2-3, 1998, Pages 171-178

  Catheline, Gwénaëlle ^a   Guilbaud, Gisèle ^a   Kayser, Valérie ^a  

^a INSERM   (France)

Author keywords

Opioid receptor agonist; Antinociception, peripheral; Mononeuropathic rat; Paw pressure; U 69,593

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHY; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; VOCALIZATION;

ANALGESICS; ANIMALS; BENZENEACETAMIDES; INJECTIONS, INTRAVENOUS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NERVE COMPRESSION SYNDROMES; PAIN MEASUREMENT; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SCIATIC NERVE; SOMATOSTATIN;

EID: 0032544761     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00597-4     Document Type: Article

References (44)

1. Antonijevic I., Mousa S.A., Schäfer M., Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15:1995;165-172.
2. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
3. Attal N., Chen Y.L., Kayser V., Guilbaud G. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy. Pain. 47:1991;65-70.
4. Barber A., Gottschlich R. Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med. Res. Rev. 12:1992;525-562.
5. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
6. Bonetti B.B., Monaco S., Gianni C., Ferrari S., Zanusso G.L., Rizzuto N. Human peripheral nerve macrophages in normal and pathological conditions. J. Neurol. Sci. 118:1993;158-168.
7. Bourde O., Kiefer R., Toyka K.V., Hartung H.P. Quantification of interleukin-6 mRNA in Wallerian degeneration by competitive reverse transcription polymerase chain reaction. J. Neuroimmunol. 69:1996;135-140.
8. Brown M.C., Perry H.V., Lunn R.E., Gordon S., Heumann R. Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor. Neuron. 6:1991;359-370.
9. Buzas B., Cox B.M. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience. 76:1997;479-489.
10. Catheline G., Kayser V., Guilbaud G. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of κ-, but not δ-opioid receptors. Eur. J. Pharmacol. 315:1996;135-143.
11. Catheline G., Kayser V., Idänpään-Heikkilä J.J., Guilbaud G. The antinociceptive activity of κ- but not δ-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats. Eur. J. Pharmacol. 318:1996;273-281.
12. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:1995;5-8.
13. Coggeshall R.E., Zhou S., Carlton S.M. Opioid receptors on peripheral sensory axons. Brain Res. 764:1997;126-132.
14. Committee for Research and Ethical Issues of the IASP Ethical standards for investigative and experimental pain in animals. Pain. 16:1983;109-110.
15. Dahlin L.B., Miyauchi A., Thomsen P., Danielsen N., kanje M. Stimulation of nerve regeneration by macrophages in granulation tissue. Restor. Neurol. Neurosci. 9:1996;141-149.
16. Desmeules J.A., Kayser V., Guilbaud G. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain. 53:1993;277-285.
17. Fields H.L., Emson P.C., Leight B.K., Gilbert R.F.T., Iversen L.L. Multiple opiate receptor sites on primary afferent fibres. Nature. 284:1980;351-353.
18. Hassan A.H.S., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55:1993;185-195.
19. Idänpään-Heikkilä J.J., Perrot S., Guilbaud G., Kayser V. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCKB receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics. Eur. J. Pharmacol. 325:1997;155-164.
20. Jeanjean A.P., Maloteaux J.-M., Laduron P.M. IL-1β-like Freund's adjuvant enhances axonal transport of opiate receptors in sensory neurons. Neurosci. Lett. 177:1994;75-78.
21. Kayser V., Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain. 41:1990;353-363.
22. Kayser, V., Guilbaud, G., 1994. Peripheral aspects of opioid activity: studies in animals. In: Besson, J.-M., Guilbaud, G., Ollat, H. (Eds.), Pharmacological Aspects of Peripheral Neurons Involved in Nociception. John Libbey Eurotext, Paris, pp. 135-155.
23. Kayser V., Gobeaux D., Lombard M.C., Guilbaud G., Besson J.M. Potent and long lasting antinociceptive effects after injection of low doses of a mu-opioid receptor agonist, fentanyl, into the brachial plexus sheath of the rat. Pain. 42:1990;215-225.
24. Kayser V., Lee S.H., Guilbaud G. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy. Neuroscience. 64:1995;537-545.
25. Keïta H., Kayser V., Guilbaud G. Antinociceptive effect of a κ-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur. J. Pharmacol. 277:1995;275-280.
26. 1-opioid receptor-mediated analgesia in mice. Eur. J. Pharmacol. 310:1996;141-143.
27. Li J.-L., Kaneko T., Mizuno N. Effects of peripheral nerve ligation on expression of μ-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci. Lett. 214:1996;91-94.
28. Lotan M., Solomon A., Ben-Bassat S., Schwartz M. Cytokines modulates the inflammatory responses and change permissiveness to neuronal adhesion in injured mammalian central nervous system. Exp. Neurol. 126:1994;284-290.
29. Maekawa K., Minami M., Yabuuchi K., Toya T., Katao Y., Hosoi Y., Onogi T., Satoh M. In situ hybridization study of mu- and kappa-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia. Neurosci. Lett. 168:1994;97-100.
30. Maves T.J., Pechman P.S., Gebhart G.F., Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain. 54:1993;57-69.
31. Neil A., Kayser V., Chen Y.L., Guilbaud G. Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral mononeuropathy. Brain Res. 522:1990;140-143.
32. Perry V.H., Brown M.C., Andersson P. Macrophage responses to central and peripheral nerve injury. Adv. Neurol. 59:1993;309-314.
33. Reichert R., Levitzky R., Rotshenker S. Interleukin-6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8:1996;530-535.
34. Schäfer M., Imai Y., Uhl G.R., Stein C. Inflammation enhances peripheral μ-opioid receptor-mediated analgesia, but not μ-opioid receptor transcription in dorsal root ganglia. Eur. J. Pharmacol. 279:1995;165-169.
35. Sommer C., Galbraith J.A., Heckman H.M., Meyers R.R. Pathology of experimental compression neuropathy producing hyperesthesia. J. Neuropathol. Exp. Neurol. 52:1993;223-233.
36. Sommer C., Marziniak M., Myers R.R. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain. 74:1998;83-91.
37. Stein C. Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76:1993;182-191.
38. Stein C., Yassouridis A. Peripheral morphine analgesia. Pain. 71:1997;119-121.
39. Stein C., Millan M.J., Yassouridis A., Herz A. Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced due to a peripheral opioid-specific mechanism. Eur. J. Pharmacol. 155:1988;255-264.
40. Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248:1989;1269-1275.
41. Stoll G., Hartung H.P. The role of macrophages in degeneration and immune-mediated demyelination of the peripheral nervous system. Adv. Neuroimmunol. 2:1992;163-179.
42. Taiwo Y.O., Levine J.D. Kappa and delta-opioids block sympathetically dependent hyperalgesia. J. Neurosci. 11:1991;928-932.
43. Wagner R., Myers R.R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
44. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endothelial TNF-α expression. Pain. 74:1998;35-42.